Patient Guide: AN INTERVENTIONAL PHASE 2/3 DOSE EXPANSION FOLLOWED BY A RANDOMIZED, DOUBLE-BLIND STUDY OF PF-08634404 IN COMBINATION WITH CHEMOTHERAPY IN PATIENTS WITH EXTENSIVE-STAGE SMALL CELL LUNG CANCER

We'll Help You Connect with This Trial

Quri.ai is a free clinical trial matching service. We help patients like you connect directly with research sites conducting this study.

  • Get matched to the right study location for you
  • Connect directly with study coordinators at multiple participating sites
  • Understand eligibility with our simplified screening tool
  • Free service - we're here to help you access clinical research
Trial ID: NCT6461004
Status: 🟢 Enrolling Now
Condition: Small cell lung cancer
Phase: PHASE2, PHASE3

Loading interactive enrollment tools...

The full interactive experience will load momentarily